25 May 2013
Keywords: b-ms, ixempra, increases, pfs, triple, negative, bc
Article | 22 December 2008
US drug major Bristol-Myers Squibb says new study data show that Ixempra (ixabepilone) plus capecitabine resulted in a significant increase ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2008
24 May 2013
© 2013 thepharmaletter.com